RhumbLine Advisers’s Global Medical REIT GMRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$793K Buy
114,429
+10,141
+10% +$70.3K ﹤0.01% 2370
2025
Q1
$913K Sell
104,288
-4,574
-4% -$40K ﹤0.01% 2221
2024
Q4
$840K Buy
108,862
+2,731
+3% +$21.1K ﹤0.01% 2330
2024
Q3
$1.05M Sell
106,131
-4,211
-4% -$41.7K ﹤0.01% 2244
2024
Q2
$1M Buy
110,342
+5,696
+5% +$51.7K ﹤0.01% 2246
2024
Q1
$916K Sell
104,646
-2,379
-2% -$20.8K ﹤0.01% 2302
2023
Q4
$1.19M Buy
107,025
+426
+0.4% +$4.73K ﹤0.01% 2165
2023
Q3
$956K Sell
106,599
-397
-0.4% -$3.56K ﹤0.01% 2236
2023
Q2
$977K Sell
106,996
-1,035
-1% -$9.45K ﹤0.01% 2302
2023
Q1
$984K Buy
108,031
+2,238
+2% +$20.4K ﹤0.01% 2125
2022
Q4
$1M Buy
105,793
+1,444
+1% +$13.7K ﹤0.01% 2125
2022
Q3
$889K Buy
104,349
+5,188
+5% +$44.2K ﹤0.01% 2194
2022
Q2
$1.11M Buy
99,161
+12,457
+14% +$140K ﹤0.01% 2084
2022
Q1
$1.42M Sell
86,704
-358
-0.4% -$5.84K ﹤0.01% 1978
2021
Q4
$1.55M Buy
87,062
+1,527
+2% +$27.1K ﹤0.01% 2015
2021
Q3
$1.26M Buy
85,535
+6,048
+8% +$88.9K ﹤0.01% 2131
2021
Q2
$1.17M Buy
79,487
+8,186
+11% +$121K ﹤0.01% 2173
2021
Q1
$935K Sell
71,301
-2,817
-4% -$36.9K ﹤0.01% 2218
2020
Q4
$968K Buy
74,118
+9,628
+15% +$126K ﹤0.01% 2142
2020
Q3
$871K Sell
64,490
-13,868
-18% -$187K ﹤0.01% 2046
2020
Q2
$888K Buy
78,358
+13,262
+20% +$150K ﹤0.01% 2090
2020
Q1
$659K Buy
65,096
+13,661
+27% +$138K ﹤0.01% 2051
2019
Q4
$680K Buy
51,435
+2,218
+5% +$29.3K ﹤0.01% 2239
2019
Q3
$561K Buy
49,217
+4,742
+11% +$54.1K ﹤0.01% 2274
2019
Q2
$467K Buy
44,475
+12,095
+37% +$127K ﹤0.01% 2390
2019
Q1
$318K Sell
32,380
-42,843
-57% -$421K ﹤0.01% 2515
2018
Q4
$669K Buy
75,223
+52,755
+235% +$469K ﹤0.01% 2165
2018
Q3
$212K Buy
22,468
+881
+4% +$8.31K ﹤0.01% 2702
2018
Q2
$191K Buy
21,587
+4,555
+27% +$40.3K ﹤0.01% 2747
2018
Q1
$118K Buy
17,032
+610
+4% +$4.23K ﹤0.01% 2717
2017
Q4
$135K Sell
16,422
-2,422
-13% -$19.9K ﹤0.01% 2728
2017
Q3
$169K Buy
18,844
+1,145
+6% +$10.3K ﹤0.01% 2797
2017
Q2
$158K Buy
17,699
+5,710
+48% +$51K ﹤0.01% 2820
2017
Q1
$109K Buy
11,989
+1,490
+14% +$13.5K ﹤0.01% 2768
2016
Q4
$94K Buy
+10,499
New +$94K ﹤0.01% 2798